In this regard, the most common intracellular pathways related to SCLC carcinogenesis are represented by the PI3K/AKT/mTOR (mammalian target of rapamycin) (activating mutations) and PTEN (loss of function) pathways [72,89,90,91,92,93]. Here, MTOR is linked to small cell lung carcinoma.